Matches in SemOpenAlex for { <https://semopenalex.org/work/W4296807426> ?p ?o ?g. }
- W4296807426 endingPage "e0272362" @default.
- W4296807426 startingPage "e0272362" @default.
- W4296807426 abstract "We report herein, the design and synthesis of thiazolidine-2,4-diones derivatives as new inhibitors for VEGFR-2. The designed members were assessed for their in vitro anticancer activity against four cancer cell lines; A549, Caco-2, HepG-2 and MDA-MB-231. Compound 14a showed the most potent effects against Caco-2, and HepG-2 cell lines (IC50 = of 1.5 and 31.5 μM, respectively). Next, the in vitro VEGFR-2 inhibitory activity, safety profiles and selectivity indices were examined for all the synthesized members against the normal Vero cell line. Compound 14a (the safest member against Caco-2 cell line) was further investigated for its ability to inhibit Caco-2 cells migration and healing. Moreover, the apoptotic induction of compound 14a against Caco-2 cell line was investigated by assessing against four apoptotic genes (Bcl2, Bcl-xl, TGF, and Survivin). The results revealed that compound 14a can exert apoptosis through significant reduction of Bcl2, Survivin, and TGF gene expression levels. Finally, deep computational studies including molecular docking, ADMET, toxicity studies, and MD simulation were carried out. Also, the DFT calculations were performed and discussed, and the results confirmed the inhibitory reactivity of 14a against VEGFR-2. Compound 14a is expected to be used as a potential lead in the development of new VEGFR-2 inhibitors with increased potency." @default.
- W4296807426 created "2022-09-24" @default.
- W4296807426 creator A5007786874 @default.
- W4296807426 creator A5014309153 @default.
- W4296807426 creator A5020589815 @default.
- W4296807426 creator A5028807146 @default.
- W4296807426 creator A5048991764 @default.
- W4296807426 creator A5062666165 @default.
- W4296807426 creator A5070924066 @default.
- W4296807426 creator A5074335644 @default.
- W4296807426 creator A5078683293 @default.
- W4296807426 creator A5086351593 @default.
- W4296807426 creator A5088150567 @default.
- W4296807426 date "2022-09-23" @default.
- W4296807426 modified "2023-10-09" @default.
- W4296807426 title "Design, synthesis, anti-proliferative evaluation, docking, and MD simulations studies of new thiazolidine-2,4-diones targeting VEGFR-2 and apoptosis pathway" @default.
- W4296807426 cites W1416958482 @default.
- W4296807426 cites W1966651561 @default.
- W4296807426 cites W1978253274 @default.
- W4296807426 cites W1982766494 @default.
- W4296807426 cites W1991112446 @default.
- W4296807426 cites W1992905076 @default.
- W4296807426 cites W1994404726 @default.
- W4296807426 cites W2015807628 @default.
- W4296807426 cites W2021520922 @default.
- W4296807426 cites W2031737454 @default.
- W4296807426 cites W2039425860 @default.
- W4296807426 cites W2055242813 @default.
- W4296807426 cites W2055265038 @default.
- W4296807426 cites W2062610629 @default.
- W4296807426 cites W2068311282 @default.
- W4296807426 cites W2072198035 @default.
- W4296807426 cites W2073532176 @default.
- W4296807426 cites W2088686339 @default.
- W4296807426 cites W2091774189 @default.
- W4296807426 cites W2100592123 @default.
- W4296807426 cites W2118571345 @default.
- W4296807426 cites W2132262459 @default.
- W4296807426 cites W2138787512 @default.
- W4296807426 cites W2152964937 @default.
- W4296807426 cites W2166689953 @default.
- W4296807426 cites W2171405825 @default.
- W4296807426 cites W2177929699 @default.
- W4296807426 cites W2206954826 @default.
- W4296807426 cites W2253996148 @default.
- W4296807426 cites W2501769632 @default.
- W4296807426 cites W2576376115 @default.
- W4296807426 cites W2603120023 @default.
- W4296807426 cites W2733930358 @default.
- W4296807426 cites W2796152634 @default.
- W4296807426 cites W2889072707 @default.
- W4296807426 cites W2892113269 @default.
- W4296807426 cites W2939027651 @default.
- W4296807426 cites W2958973731 @default.
- W4296807426 cites W2988361120 @default.
- W4296807426 cites W3039947924 @default.
- W4296807426 cites W3081848457 @default.
- W4296807426 cites W3082495518 @default.
- W4296807426 cites W3113558763 @default.
- W4296807426 cites W3133431544 @default.
- W4296807426 cites W3133533360 @default.
- W4296807426 cites W3157791576 @default.
- W4296807426 cites W3159182064 @default.
- W4296807426 cites W3163986876 @default.
- W4296807426 cites W3171103037 @default.
- W4296807426 cites W3174095671 @default.
- W4296807426 cites W3180992221 @default.
- W4296807426 cites W3186877437 @default.
- W4296807426 cites W3186998122 @default.
- W4296807426 cites W3187522263 @default.
- W4296807426 cites W3187698246 @default.
- W4296807426 cites W3195108149 @default.
- W4296807426 cites W3206811405 @default.
- W4296807426 cites W3208102345 @default.
- W4296807426 cites W3210983984 @default.
- W4296807426 cites W4200207022 @default.
- W4296807426 cites W4200291296 @default.
- W4296807426 cites W4210306615 @default.
- W4296807426 cites W4212795945 @default.
- W4296807426 cites W4212820642 @default.
- W4296807426 cites W4214520590 @default.
- W4296807426 cites W4214826295 @default.
- W4296807426 cites W4220934822 @default.
- W4296807426 cites W4224324545 @default.
- W4296807426 doi "https://doi.org/10.1371/journal.pone.0272362" @default.
- W4296807426 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36149902" @default.
- W4296807426 hasPublicationYear "2022" @default.
- W4296807426 type Work @default.
- W4296807426 citedByCount "19" @default.
- W4296807426 countsByYear W42968074262022 @default.
- W4296807426 countsByYear W42968074262023 @default.
- W4296807426 crossrefType "journal-article" @default.
- W4296807426 hasAuthorship W4296807426A5007786874 @default.
- W4296807426 hasAuthorship W4296807426A5014309153 @default.
- W4296807426 hasAuthorship W4296807426A5020589815 @default.
- W4296807426 hasAuthorship W4296807426A5028807146 @default.
- W4296807426 hasAuthorship W4296807426A5048991764 @default.
- W4296807426 hasAuthorship W4296807426A5062666165 @default.